Order Article Reprints

Malagón-Rojas J, Mercado-Reyes M, Toloza-Pérez YG, Galindo M, Palma RM, Catama J, Bedoya JF, Parra-Barrera EL, Meneses X, Barbosa J, et al. Comparison of Anti-SARS-CoV-2 IgG Antibody Responses Generated by the Administration of Ad26.COV2.S, AZD1222, BNT162b2, or CoronaVac: Longitudinal Prospective Cohort Study in the Colombian Population, 2021/2022. Vaccines. 2022; 10(10):1609. https://doi.org/10.3390/vaccines10101609

Malagón-Rojas, Jeadran, Marcela Mercado-Reyes, Yesith G. Toloza-Pérez, Marisol Galindo, Ruth M. Palma, Jenssy Catama, Juan F. Bedoya, Eliana L. Parra-Barrera, Ximena Meneses, Juliana Barbosa, and et al. 2022. "Comparison of Anti-SARS-CoV-2 IgG Antibody Responses Generated by the Administration of Ad26.COV2.S, AZD1222, BNT162b2, or CoronaVac: Longitudinal Prospective Cohort Study in the Colombian Population, 2021/2022" Vaccines 10, no. 10: 1609. https://doi.org/10.3390/vaccines10101609

Malagón-Rojas, J., Mercado-Reyes, M., Toloza-Pérez, Y. G., Galindo, M., Palma, R. M., Catama, J., Bedoya, J. F., Parra-Barrera, E. L., Meneses, X., Barbosa, J., Tavera-Rodríguez, P., Bermúdez-Forero, A., & Ospina-Martínez, M. L. (2022). Comparison of Anti-SARS-CoV-2 IgG Antibody Responses Generated by the Administration of Ad26.COV2.S, AZD1222, BNT162b2, or CoronaVac: Longitudinal Prospective Cohort Study in the Colombian Population, 2021/2022. Vaccines, 10(10), 1609. https://doi.org/10.3390/vaccines10101609